These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 99837)

  • 1. Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor).
    Hedner U; Martinsson G
    Thromb Res; 1978 Jun; 12(6):1015-23. PubMed ID: 99837
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Hageman factor (coagulation factor XII) for neutrophil locomotion and chemotaxis.
    Keller HU; Beck EA; Hess MW; Cottier H
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):309-13. PubMed ID: 591099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid phase activation of Hageman factor (factor XII) in citrated human plasma by bromelain: an application to the indirect enzymatic assay for Hageman factor.
    Oh-ishi S
    Thromb Res; 1982 Sep; 27(5):619-23. PubMed ID: 6983741
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of collagen on fibrinolysis.
    Engel AM; Alexander B
    Thromb Diath Haemorrh Suppl; 1973; 56():63-74. PubMed ID: 4376277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 10. The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin).
    Leung KC; Byatt JA; Stephens RW
    Thromb Res; 1987 Jun; 46(6):755-66. PubMed ID: 2957818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factor XIIa (activated Hageman factor) inhibitor from adult Schistosoma mansoni.
    Tsang VC; Hubbard WJ; Damian RT
    Am J Trop Med Hyg; 1977 Mar; 26(2):243-7. PubMed ID: 848647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin).
    Leung KC; Byatt JA; Stephens RW
    Thromb Res; 1987 Jun; 46(6):767-77. PubMed ID: 3114909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor.
    Lecander I; Roblin R; Astedt B
    Br J Haematol; 1984 Jul; 57(3):407-12. PubMed ID: 6430331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematological prospect in 1981, particularly in the field of coagulation and fibrinolysis.
    Abe T
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):11-16. PubMed ID: 6810621
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.
    Ogston D; Ogston CM; Ratnoff OD; Forbes CD
    J Clin Invest; 1969 Oct; 48(10):1786-801. PubMed ID: 4241814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.